Mark Scott - Concepedia

Concepedia

Author

Mark Scott

National Eye Institute

Also Known As

M H Scott, M SCOTT, M Scott, M. SCOTT, M. Scott, Mark H Scott, Mark H. Scott, Mark Scott

33

Publications

1.2K

Citations

17

H-Index

43

Concepts

All Affiliations

National Eye Institute Mayo Clinic University of Oklahoma Oakland University Osmania University

MS

About

Mark Scott is an author at National Eye Institute specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	475
2	Engineering	2	2	30
3	Health Sciences	1	1	23
4	Anatomy	1	1	23
5	Biochemistry	1	1	94

Mark Scott

×

20

Publications

1.2K

Citations

17

H-Index

	Year	Citations
Carcinoma of the anal canal, a clinical and pathologic study of 188 cases Bruce M. Boman, Charles G. Moertel, Michael J. O’Connell, Cancer	1984	444
Autosomal Dominant Congenital Cataract Mark Scott, J. Fielding Hejtmancik, Laura A. Wozencraft, Ophthalmology CataractOcular DiseaseOphthalmologyPediatric Ophthalmology	1994	106
A 5-base insertion in the γC-crystallin gene is associated with autosomal dominant variable zonular pulverulent cataract Zhaoxia Ren, Anren Li, Barker S. Shastry, Human Genetics Ocular DiseaseOphthalmologyGeneticsGlaucomaγC-crystallin Gene	2000	94
Inhibition of gentamicin uptake in rat renal cortex in vivo by aminoglycosides and organic polycations. C Josepovitz, E Pastoriza-Muñoz, D Timmerman, Journal of Pharmacology and Experimental Therapeutics Molecular PharmacologyRat Renal CortexUrologyGentamicin UptakePharmacological Study	1982	94
The effect of CNS metastases on the survival of patients with small cell cancer of the lung Guy A. Van Hazel, Mark Scott, Robert T. Eagan Cancer	1983	72
Zoladex versus orchiectomy in treatmentof advanced prostate cancer: a randomized trial Mark S. Soloway, Joseph A. Smith, Gerald W. Chodak, Urology UrologySurgical OncologyGenitourinary CancerMedicineZoladex Versus Orchiectomy	1991	66
Zoladex: a sustained-release, monthly luteinizing hormone-releasing hormone analogue for the treatment of advanced prostate cancer. Frederick R. Ahmann, Dennis L. Citrin, H.A. deHaan, Journal of Clinical Oncology UrologyOncologyMedicineHormone-releasing Hormone AnalogueZoladex Therapy	1987	60
A comparison of Zoladex® and DES in the treatment of advanced prostate cancer: Results of a randomized, multicenter trial Dennis L. Citrin, Martin I. Resnick, Patrick Guinan, The Prostate	1991	33
Ankyloblepharon Filiforme Adnatum Associated With Infantile Glaucoma and Iridogoniodysgenesis Mark Scott, J Richard, Bradley K. Farris Journal of Pediatric Ophthalmology & Strabismus Ocular DiseaseDevelopmental BiologyOphthalmologySurgical PathologyHistopathology	1994	27
A comparison of short-course, low-dose and long-course, high-dose preoperative radiation for carcinoma of the bladder Paul W. Scanlon, Mark Scott, Joseph W. Segura Cancer Bladder CarcinomaUrologySurgical OncologyRadiation TherapyGood Prognosis	1983	23

Page 1